Stock listing
Frankfurt:77E MediNice SA Aktie
German listing (Frankfurt) of MediNice SA · home listing GPW:ICE
Follow MediNice SA into a list and get an email when it puts out news.
Home listing price · GPW:ICE
44.50 PLN -0.90 (-2.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, GPW:ICE
- Day range
- 43.00 – 45.00 PLNNov 20, 2026
- Volume
- 27,993 sharesNov 20, 2026
- Market cap
- 465.1M PLNAt the close on Nov 20, 2026 · price × 10.45M shares outstanding
- 52-week range
- 10.14 – 95.10 PLNLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 1.75M PLNMedian day 20,390 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| GPW:ICE · Home | 44.50 PLN | -0.90 (-2.0%) | 27,993 | 44.25 | 45.00 | 43.00 | 45.40 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · GPW:ICE · PLN, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 44.50 | -0.90 | -2.0% | 44.25 | 45.00 | 43.00 | 27,993 | |
| 45.40 | -0.80 | -1.7% | 45.80 | 46.65 | 45.05 | 23,118 | |
| 46.20 | -0.35 | -0.8% | 45.90 | 47.50 | 45.20 | 20,372 | |
| 46.55 | -3.25 | -6.5% | 49.35 | 49.80 | 45.95 | 26,651 | |
| 49.80 | +1.35 | +2.8% | 48.90 | 51.40 | 46.40 | 31,588 | |
| 48.45 | +3.05 | +6.7% | 45.30 | 49.00 | 45.00 | 47,895 | |
| 45.40 | -3.50 | -7.2% | 48.50 | 49.00 | 43.90 | 188,789 | |
| 48.90 | -1.60 | -3.2% | 50.10 | 50.90 | 47.60 | 22,843 | |
| 50.50 | -2.50 | -4.7% | 52.50 | 53.00 | 50.00 | 37,349 | |
| 53.00 | -2.10 | -3.8% | 55.70 | 57.60 | 51.90 | 22,396 | |
| 55.10 | -1.60 | -2.8% | 56.40 | 56.50 | 54.80 | 11,794 | |
| 56.70 | +2.40 | +4.4% | 54.10 | 56.80 | 54.00 | 33,434 | |
| 54.30 | -0.10 | -0.2% | 55.40 | 55.40 | 52.30 | 22,136 | |
| 54.40 | -0.90 | -1.6% | 55.30 | 55.80 | 53.20 | 15,432 | |
| 55.30 | +2.20 | +4.1% | 53.80 | 55.50 | 52.80 | 10,416 | |
| 53.10 | -0.70 | -1.3% | 53.80 | 54.70 | 52.00 | 7,363 | |
| 53.80 | +0.70 | +1.3% | 53.20 | 56.00 | 52.00 | 16,304 | |
| 53.10 | +0.40 | +0.8% | 53.00 | 53.70 | 51.90 | 7,792 | |
| 52.70 | -0.70 | -1.3% | 51.60 | 56.70 | 51.60 | 25,332 | |
| 53.40 | -0.40 | -0.7% | 53.90 | 54.80 | 51.80 | 12,293 | |
| 53.80 | +0.20 | +0.4% | 53.50 | 55.20 | 51.80 | 7,566 | |
| 53.60 | -1.80 | -3.2% | 55.20 | 55.30 | 52.90 | 17,755 | |
| 55.40 | -0.80 | -1.4% | 57.50 | 59.50 | 55.40 | 14,338 | |
| 56.20 | +0.90 | +1.6% | 56.40 | 57.60 | 55.30 | 6,119 | |
| 55.30 | -1.70 | -3.0% | 57.00 | 57.40 | 55.00 | 18,290 | |
| 57.00 | -0.50 | -0.9% | 57.90 | 58.90 | 56.70 | 9,273 | |
| 57.50 | -0.20 | -0.3% | 57.00 | 58.00 | 56.40 | 15,869 | |
| 57.70 | -2.80 | -4.6% | 61.00 | 61.00 | 56.80 | 33,462 | |
| 60.50 | +1.20 | +2.0% | 59.30 | 60.90 | 58.30 | 20,390 | |
| 59.30 | +3.10 | +5.5% | 56.20 | 64.00 | 55.80 | 53,516 | |
| 56.20 | +2.10 | +3.9% | 56.00 | 57.00 | 54.20 | 25,146 | |
| 54.10 | -1.40 | -2.5% | 55.50 | 57.30 | 53.60 | 24,588 | |
| 55.50 | -1.30 | -2.3% | 56.50 | 57.80 | 55.00 | 18,189 | |
| 56.80 | -1.20 | -2.1% | 57.20 | 58.80 | 56.40 | 12,283 | |
| 58.00 | -0.20 | -0.3% | 59.00 | 59.60 | 56.50 | 14,997 | |
| 58.20 | +1.80 | +3.2% | 57.50 | 59.80 | 57.30 | 50,955 | |
| 56.40 | +0.30 | +0.5% | 56.30 | 57.00 | 54.60 | 17,276 | |
| 56.10 | -0.80 | -1.4% | 58.00 | 58.30 | 55.60 | 14,026 | |
| 56.90 | -2.00 | -3.4% | 58.20 | 59.50 | 56.70 | 16,030 | |
| 58.90 | -2.10 | -3.4% | 60.30 | 61.20 | 58.50 | 11,201 | |
| 61.00 | +1.40 | +2.3% | 59.50 | 61.30 | 57.90 | 35,659 | |
| 59.60 | +0.20 | +0.3% | 59.90 | 61.80 | 59.00 | 19,158 | |
| 59.40 | -2.70 | -4.3% | 61.40 | 61.80 | 58.40 | 36,097 | |
| 62.10 | -1.30 | -2.1% | 67.60 | 67.60 | 62.00 | 66,776 | |
| 63.40 | +5.00 | +8.6% | 57.70 | 63.40 | 57.20 | 49,337 | |
| 58.40 | +1.00 | +1.7% | 57.50 | 58.90 | 55.60 | 32,055 | |
| 57.40 | -2.50 | -4.2% | 60.00 | 60.50 | 57.40 | 12,300 | |
| 59.90 | +0.90 | +1.5% | 59.10 | 60.60 | 58.10 | 17,939 | |
| 59.00 | +1.00 | +1.7% | 58.00 | 60.00 | 57.00 | 24,701 | |
| 58.00 | -0.60 | -1.0% | 58.50 | 59.20 | 54.60 | 109,421 | |
| 58.60 | -2.40 | -3.9% | 60.90 | 60.90 | 58.40 | 50,294 | |
| 61.00 | -2.00 | -3.2% | 63.00 | 63.00 | 58.60 | 34,471 | |
| 63.00 | +1.40 | +2.3% | 62.60 | 63.50 | 60.70 | 32,478 | |
| 61.60 | -2.90 | -4.5% | 65.70 | 66.00 | 60.30 | 70,160 | |
| 64.50 | -5.20 | -7.5% | 70.30 | 70.30 | 57.00 | 226,813 | |
| 69.70 | -3.40 | -4.7% | 72.90 | 72.90 | 69.40 | 21,777 | |
| 73.10 | +1.00 | +1.4% | 72.00 | 74.50 | 69.40 | 29,961 | |
| 72.10 | +0.60 | +0.8% | 75.50 | 76.00 | 71.70 | 24,014 | |
| 71.50 | +1.10 | +1.6% | 71.20 | 72.90 | 69.30 | 11,283 | |
| 70.40 | -1.90 | -2.6% | 72.00 | 72.20 | 69.60 | 15,755 | |
| 72.30 | 0.00 | 0.0% | 72.30 | 72.90 | 71.40 | 8,358 | |
| 72.30 | -1.40 | -1.9% | 74.00 | 74.00 | 71.50 | 6,344 | |
| 73.70 | -0.50 | -0.7% | 74.50 | 75.00 | 71.80 | 15,238 | |
| 74.20 | -0.80 | -1.1% | 74.60 | 76.00 | 73.00 | 6,626 | |
| 75.00 | +2.00 | +2.7% | 73.60 | 75.20 | 73.00 | 12,348 |
- Ticker
- Frankfurt:77E
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest deck · April 2026
Investor Presentation (April 2026)
Investor deck · 28 slides
MediNice SA on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- Decks
- 4 decks · latest April 2026
Where MediNice SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| GPW:ICE · Home listing | GPW | Poland | PLN |
| Frankfurt:77E · This page | Frankfurt | Germany | EUR |
Valuation
Price/book 5.5× against a median of 1.1×: the highest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 461.4M PLN
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 5.5×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| MediNice SA · GPW:ICE | US$114.6M | US$113.7M | n/a | n/a | n/a | 5.5× | n/a | 0.0× | n/a |
| Mercator Medical SA · GPW:MRC | US$123.9M | US$87.99M | 7.6× | 0.6× | 4.5× | 0.5× | 10.7% | 0.0× | n/a |
| i-SENS, Inc. · KRX:099190 | US$123.6M | US$118.1M | n/a | 0.5× | 5.6× | 0.5× | −0.8% | 0.2× | n/a |
| Edap Tms SA · NASDAQ:FOCL | US$123.2M | US$103.0M | n/a | 1.3× | n/a | 3.4× | −47.0% | 1.0× | 1.17 |
| St.Shine Optical Co., Ltd. · TPEX:1565 | US$117.8M | US$48.96M | 8.5× | 0.4× | 2.0× | 0.6× | 11.1% | 0.0× | n/a |
| Allgens Medical Technology Co. Ltd. Class A · SSE:688613 | US$112.7M | −US$36.23M | 94.7× | −1.1× | n/a | 0.5× | 3.5% | 0.0× | n/a |
| Aroa Biosurgery Ltd · ASX:ARX | US$112.6M | US$101.1M | 40.9× | 1.7× | 16.9× | 2.1× | 4.5% | 0.1× | n/a |
| Pulmonx Corporation · NASDAQ:LUNG | US$111.9M | US$97.15M | n/a | 1.1× | n/a | 3.3× | −47.9% | 1.1× | 1.95 |
| Laxmi Dental Ltd. · NSE:LAXMIDENTL | US$111.4M | US$110.1M | 31.9× | 3.5× | 20.4× | 3.9× | 11.0% | 0.1× | n/a |
| Onward Medical N.V. · EURONEXT:ONWD | US$106.1M | US$31.75M | n/a | 5.3× | n/a | 1.3× | −771.8% | 0.2× | n/a |
| Interojo Inc. · KRX:119610 | US$105.7M | US$84.13M | 8.0× | 0.9× | 3.4× | 0.9× | 14.3% | 0.0× | n/a |
| Median of the others | US$112.6M | US$92.57M | 20.2× | 1.0× | 5.1× | 1.1× | 4.0% | 0.1× | 1.56 |
Team and board
| Officer | Role |
|---|---|
| Sanjeev Choudhary | Chief Executive Officer |
| Piotr Łoziński | Chief Financial Officer |
| Paweł Sobkiewicz | Chief Operating Officer |
| Grzegorz Wróblewski | Chief Technology Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 6, 2026 | −7.7% |
| Q2 2026 | Sep 11, 2026 | +3.3% |
| Q1 2026 | May 11, 2026 | +1.9% |
| Q4 2025 | Mar 18, 2026 | −3.2% |
| Q3 2025 | Dec 3, 2025 | +18.3% |
| Q2 2025 | Sep 3, 2025 | +8.3% |
| Q1 2025 | May 28, 2025 | −3.5% |
| Q4 2024 | Feb 26, 2025 | +0.3% |
| Q3 2024 | Nov 27, 2024 | +1.3% |
| Q2 2024 | Aug 28, 2024 | −0.6% |
All 17 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 29, 2024 | +0.1% |
| Q4 2023 | Feb 28, 2024 | −3.1% |
| Q3 2023 | Nov 29, 2023 | +1.6% |
| Q2 2023 | Aug 30, 2023 | +1.8% |
| Q1 2023 | May 31, 2023 | −0.3% |
| Q4 2022 | Mar 1, 2023 | −1.6% |
| Q3 2022 | Nov 30, 2022 | +8.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (April 2026) | Investor deck | 28 slides | April 2026 |
| Investor Presentation (February 2026) | Investor deck | 28 slides | February 2026 |
| Investor Presentation (2025) | Investor deck | 22 slides | Nov 13, 2025 |
| Corporate Update (June 2025) | Corporate update | 18 slides | Jun 24, 2025 |
Financials
Annual, in PLN
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 188.0K | 225.0K | 246.0K | 285.0K | 372.0K | 164.4K | 1.11K | 243.0K | 184.7K |
| Cost of revenue | 166.0K | 214.0K | 150.0K | 111.0K | 74.0K | 122.0K | 29.2K | 23.3K | 15.0K | 15.1K |
| Gross profit | -166.0K | -26.0K | 75.0K | 135.0K | 214.0K | 250.0K | 135.2K | -22.2K | 228.0K | 169.6K |
| Research and development | 6.00K | 75.0K | 75.0K | 85.0K | 80.0K | 69.0K | ||||
| Selling, general and administrative | 1.36M | 1.36M | 1.52M | 1.26M | 1.02M | 643.9K | 434.9K | |||
| Operating income | -6.78M | 37.2M | -5.78M | -5.00M | -3.29M | -2.46M | -1.98M | -1.73M | -618.0K | -303.5K |
| Depreciation and amortization | 242.0K | 230.0K | 358.0K | 314.0K | 362.0K | 362.0K | 99.3K | 51.0K | 6.67K | 7.93K |
| EBITDA | -6.54M | 37.5M | -5.42M | -4.68M | -2.92M | -2.10M | -1.88M | -1.68M | -611.4K | -295.6K |
| Interest expense | 42.0K | 52.0K | 62.0K | 75.0K | 59.0K | 47.0K | 10.0K | 9.17K | 25.7K | 15.6K |
| Income before tax | -6.74M | 37.6M | -5.07M | -4.92M | -2.88M | -3.02M | -2.02M | -1.73M | -645.0K | -319.8K |
| Income tax | -14.0K | -25.0K | 0 | 10.0K | 228.5K | 5.88K | 502 | 138 | ||
| Net income | -6.72M | 37.6M | -5.07M | -4.92M | -2.88M | -3.02M | -2.25M | -1.65M | -507.2K | -320.6K |
| Earnings per share, basic | -0.80 | 5.62 | -0.79 | -0.79 | -0.50 | -0.56 | -0.51 | -0.50 | -0.15 | -0.10 |
| Earnings per share, diluted | -0.77 | -0.48 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 9.60M | 9.12M | 10.3M | 21.2M | 31.9M | 11.5M | 5.51M | 3.54M | 1.85M | 3.81K |
| Short-term investments | 3.00K | 630.0K | 75.0K | 22.0K | 25.9K | 10.00K | -85.2K | |||
| Receivables | 6.00K | 701.0K | 583.0K | 741.0K | 918.0K | 691.0K | 391.0K | 2.23M | 820.7K | 807.3K |
| Inventory | 3.72M | -445.0K | ||||||||
| Current assets | 9.95M | 9.85M | 10.9M | 21.9M | 32.9M | 13.4M | 10.7M | 5.97M | 3.49M | 885.0K |
| Property, plant and equipment | 831.0K | 532.0K | 996.0K | 1.21M | 29.5K | 41.5K | ||||
| Goodwill | 47.7M | 47.7M | 0 | 0 | 0 | 0 | 152.0K | 152.2K | 121.2K | |
| Total assets | 92.7M | 86.6M | 37.5M | 41.9M | 49.1M | 20.9M | 11.7M | 7.55M | 4.90M | 1.46M |
| Accounts payable | 312.0K | 981.0K | 752.0K | 625.0K | 379.0K | 274.0K | 924.0K | 197.7K | 104.0K | 181.7K |
| Current liabilities | 1.45M | 2.46M | 1.16M | 1.01M | 1.16M | 1.38M | 2.94M | 4.48M | 660.5K | 195.0K |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 236.0K | 509.3K | 149.4K | 127.0K | |
| Total debt | 365.0K | 346.0K | 506.0K | 582.0K | 764.0K | 351.0K | 509.3K | 149.4K | 127.0K | 219.4K |
| Total liabilities | 4.62M | 5.59M | 4.33M | 4.77M | 8.60M | 3.94M | 3.46M | 4.64M | 1.64M | 1.30M |
| Shareholders' equity | 88.1M | 81.0M | 33.2M | 37.1M | 40.5M | 17.0M | 8.23M | 2.92M | 3.26M | 151.9K |
| Shares outstanding | 8.45M | 6.68M | 6.40M | 6.43M | 5.76M | 5.36M | 4.36M | 3.34M | 3.34M | 3.34M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -5.58M | -3.65M | -3.45M | -2.79M | -1.71M | -3.26M | -5.14M | -1.89M | -1.70M | -625.4K |
| Capital spending | -6.07M | -3.00K | -6.47M | -448.0K | -314.0K | -82.0K | -907.3K | -39.1K | -30.8K | -31.2K |
| Free cash flow | -11.7M | -3.66M | -9.92M | -3.24M | -2.02M | -6.23M | -6.04M | -1.93M | -1.73M | -656.5K |
| Cash from investing | -6.07M | -7.34M | -6.73M | -4.12M | -6.63M | -2.49M | -1.03M | -138.0K | -44.8K | -31.2K |
| Cash from financing | 12.1M | 9.80M | -691.0K | -3.85M | 28.7M | 11.8M | 8.13M | 3.73M | 3.58M | 525.4K |
| Share buybacks | 11.5M | 7.59M | 1.30M | 3.62M | ||||||
| Change in cash | 481.0K | -1.20M | -10.9M | -10.8M | 20.4M | 6.02M | 1.97M | 1.70M | 1.84M | -131.1K |
Cap table
Built by 6ix from MediNice SA’s releases
- Common shares
- 10,451,639
- Fully diluted
- 10,451,639
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 10,451,639 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 10,451,639 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Grzegorz Wróblewski | Chief Technology Officer · Since at least Nov 5, 2026 |
| Paweł Sobkiewicz | Chief Operating Officer · Since at least Nov 5, 2026 |
| Piotr Łoziński | Chief Financial Officer · Since at least Nov 5, 2026 |
| Sanjeev Choudhary | Chief Executive Officer · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about MediNice SA.